ABU DHABI – Mubasher: Profits of Gulf pharmaceutical industries fall “Zulfar“87 percent at the end of the first half of this year, compared to the profit for the same period last year.
In a report to the Abu Dhabi Stock Exchange, Zulbar explained that its profit at the end of the first half of 2022 fell to 6.3 million dirhams, compared to a profit of 49.9 million dirhams achieved in 2021.
General and administrative expenses increased by 185% to reach 118.7 million dirhams, compared to 41.6 million dirhams in the first half of 2021.
Selling and distribution expenses increased by 77% to reach 172.7 million dirhams, compared to 97.4 million dirhams in the same period of the previous year..
Finance expenses increased by 64% to 15.1 million dirhams, compared to 9.2 million dirhams in the first half of 2021, while other income decreased by 48% to 36.3 million dirhams, compared to 69.3 million dirhams in the same period last year. Year..
Gulf Pharmaceutical Industries “Julphar” has posted a profit in the first quarter of this year compared to the first quarter of last year..
The company indicated that the group’s net profit for the first quarter of 2022 was 1.9 million dirhams, compared to a loss of 29.2 million dirhams in the first quarter of 2021..
To trade and invest in the Egyptian stock market, click here
Appointments
“Emirates Aktia is exploring new acquisitions worth Dh1.5 billion
Backed by acquisitions, UAE “Agthia’s” profit grew 74% in the first half of 2022.
